LncRNA AC093850.2 predicts poor outcomes in patients with triple-negative breast cancer and motivates tumor progression by sponging miR-4299
Acta Biochimica Polonica · 2023
DOI: 10.18388/abp.2020_6227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica Polonica, 2023. Verfasst von Zhangbo Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, The Third People's Hospital of Chengdu, Chengdu, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, RNA, Long Noncoding, MicroRNAs. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Background
Accumulating evidence displays that non-coding RNAs (ncRNAs) are involved in the progression of triple-negative breast cancer (TNBC). This study aimed to investigate the role of lncRNA AC093850.2 in TNBC.
Methods
The AC093850.2 levels were compared using RT-qPCR in TNBC tissues and corresponding normal tissues. The Kaplan-Meier curve method was conducted to assess the clinical significance of AC093850.2 in TNBC. Bioinformatic analysis was used to predict potential miRNA. Cell proliferation and invasion assays were carried out to explore the function of AC093850.2/miR-4299 in TNBC. Results: lncRNA AC093850.2 expression is raised in TNBC tissues and cell lines, which is related to the shorter overall survival of patients. AC093850.2 is directly bound to miR-4299 in TNBC cells. Downregulation of AC093850.2 reduces tumor cell proliferation, migration, and invasion abilities, while miR-4299 silence attenuated AC093850.2 silencing induced inhibition of cellular activities in TNBC cells.
Conclusion
In general, the findings suggest that lncRNA AC093850.2 was closely related to the prognosis and progression of TNBC by sponging miR-4299, which might be a prognosis predictor and potential target for treating TNBC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Breast and Thyroid Surgery, The Third People's Hospital of Chengdu, Chengdu, China.
- Department of Breast Surgery, Weifang People's Hospital, Weifang, China.
- Department of Infectious Diseases, Weifang People's Hospital, Weifang, China.
Zitieren
APA
Xu, Z., Gu, Y., Lei, Y., & Teng, L. (2023). LncRNA AC093850.2 predicts poor outcomes in patients with triple-negative breast cancer and motivates tumor progression by sponging miR-4299. Acta Biochimica Polonica. https://doi.org/10.18388/abp.2020_6227
Vancouver
Xu Z, Gu Y, Lei Y, Teng L. LncRNA AC093850.2 predicts poor outcomes in patients with triple-negative breast cancer and motivates tumor progression by sponging miR-4299. Acta Biochimica Polonica. 2023. doi:10.18388/abp.2020_6227
BibTeX
@article{Xu2023,
author = {Xu, Zhangbo and Gu, Yongxue and Lei, Ying and Teng, Lili},
title = {LncRNA AC093850.2 predicts poor outcomes in patients with triple-negative breast cancer and motivates tumor progression by sponging miR-4299},
journal = {Acta Biochimica Polonica},
year = {2023},
doi = {10.18388/abp.2020_6227}
}
EUVIMED